First edition of our newsletter!
Check out our first newsletter, highlighting the latest information at Movmedix!
1st newsletter launch!
We proudly presents our contribution in advancing sports medicine
We proudly present the first edition of our newsletter. The last 3 years have been marked by major evolutions for our company: LARS became Movmedix on January 1st, 2023! To support these evolutions, we have decided to set up a biannual newsletter in electronic format (CSR required!) for our employees. This communication tool is a new way of sharing information about the life of our company with each and every one of you. We hope you enjoy this first edition of our Movmedix newsletter! This newsletter is more than just sharing information: it’s a way to connect, engage, and move forward together with you, our partners and collaborators. You may find all the highlights related to our growth and journey: from the new joiners arrivals, to the key milestones of 2023 and to looking into bright and exiting future in 2024 for us!
About Movmedix
Driven by our vision to restore infinite mobility to patients suffering from soft tissue injuries, Movmedix continues to evolve toward becoming a global leader in sports medicine. With more than three decades of expertise, we have been at the forefront of the artificial ligament field — pioneering free-fibre technology and designing implants tailored to specific clinical indications.
Building on the strong legacy of our LARS® (Ligament Advanced Reinforcement System) product range, we remain committed to developing innovative and disruptive solutions that address the evolving needs of surgeons and improve patient outcomes worldwide.
